SK120793A3 - 4-heterocyclylsubstituted dihydropyridines - Google Patents

4-heterocyclylsubstituted dihydropyridines Download PDF

Info

Publication number
SK120793A3
SK120793A3 SK1207-93A SK120793A SK120793A3 SK 120793 A3 SK120793 A3 SK 120793A3 SK 120793 A SK120793 A SK 120793A SK 120793 A3 SK120793 A3 SK 120793A3
Authority
SK
Slovakia
Prior art keywords
group
dihydro
pyridine
dimethyl
dicarboxylic acid
Prior art date
Application number
SK1207-93A
Other languages
English (en)
Slovak (sk)
Inventor
Bodo Junge
Wolfgang Hartwig
Heinrich Maier
Rudolf Schohe-Loop
Zhan Gao
Bernard Schmidt
De Jonge Maarten
Teunis Schuurman
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SK120793A3 publication Critical patent/SK120793A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SK1207-93A 1992-10-30 1993-10-29 4-heterocyclylsubstituted dihydropyridines SK120793A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4236707A DE4236707A1 (de) 1992-10-30 1992-10-30 4-Heterocyclyl substituierte Dihydropyridine

Publications (1)

Publication Number Publication Date
SK120793A3 true SK120793A3 (en) 1994-11-09

Family

ID=6471753

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1207-93A SK120793A3 (en) 1992-10-30 1993-10-29 4-heterocyclylsubstituted dihydropyridines

Country Status (20)

Country Link
US (1) US5502064A (fi)
EP (1) EP0595166B1 (fi)
JP (1) JPH06220047A (fi)
KR (1) KR940009180A (fi)
CN (1) CN1094403A (fi)
AT (1) ATE153335T1 (fi)
AU (1) AU4873093A (fi)
CA (1) CA2109352A1 (fi)
CZ (1) CZ227693A3 (fi)
DE (2) DE4236707A1 (fi)
DK (1) DK0595166T3 (fi)
ES (1) ES2103412T3 (fi)
FI (1) FI934778A (fi)
GR (1) GR3024295T3 (fi)
HU (1) HUT68941A (fi)
IL (1) IL107414A0 (fi)
MX (1) MX9306509A (fi)
NO (1) NO933718L (fi)
SK (1) SK120793A3 (fi)
ZA (1) ZA938088B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525600A (en) * 1994-11-28 1996-06-11 American Home Products Corporation (Thiophen-2-yl)-piperidin or tetrahydropyridin carboxamides
ATE548351T1 (de) * 1996-01-29 2012-03-15 Us Of America Represented By The Secretary Dept Of Health And Human Services Dihydropyridin-pyridin-, benzopyranon- und triazolochinazolin-derivate, deren herstellung und verwendung als adenosinrezeptor-antagonisten
WO1997037667A1 (en) 1996-04-10 1997-10-16 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of an a1 adenosine receptor agonist to treat cerebral ischaemia
KR100383514B1 (ko) * 2001-05-15 2003-05-12 한미반도체 주식회사 소형반도체 패키지 이송장치

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1545873A1 (de) * 1965-11-10 1970-02-26 Bayer Ag Verfahren zur Herstellung von Dihydrodipyridylderivaten
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
FR2320750A1 (fr) * 1975-08-12 1977-03-11 Hexachimie Dihydro-1,4 pyridines et leur application therapeutique
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3239273A1 (de) * 1982-10-23 1984-04-26 Bayer Ag, 5090 Leverkusen Tetrahydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4656181A (en) * 1982-11-24 1987-04-07 Cermol S.A. Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same
DE3445356A1 (de) * 1983-12-15 1985-06-27 Ciba-Geigy Ag, Basel Halogenierte thiophen-verbindungen
US4771057A (en) * 1986-02-03 1988-09-13 University Of Alberta Reduced pyridyl derivatives with cardiovascular regulating properties
DE3816361A1 (de) * 1987-05-18 1988-12-08 Byk Gulden Lomberg Chem Fab 1,4-dihydropyridindicarbonsaeure-(-)-menthylester

Also Published As

Publication number Publication date
FI934778A (fi) 1994-05-01
JPH06220047A (ja) 1994-08-09
ES2103412T3 (es) 1997-09-16
HUT68941A (en) 1995-08-28
HU9303083D0 (en) 1994-01-28
MX9306509A (es) 1994-04-29
NO933718L (no) 1994-05-02
IL107414A0 (en) 1994-01-25
ZA938088B (en) 1994-06-07
ATE153335T1 (de) 1997-06-15
DE4236707A1 (de) 1994-05-05
CN1094403A (zh) 1994-11-02
EP0595166A1 (de) 1994-05-04
AU4873093A (en) 1994-05-12
GR3024295T3 (en) 1997-10-31
CA2109352A1 (en) 1994-05-01
FI934778A0 (fi) 1993-10-28
US5502064A (en) 1996-03-26
KR940009180A (ko) 1994-05-20
NO933718D0 (no) 1993-10-15
CZ227693A3 (en) 1994-05-18
DE59306506D1 (de) 1997-06-26
DK0595166T3 (da) 1997-12-01
EP0595166B1 (de) 1997-05-21

Similar Documents

Publication Publication Date Title
CZ219895A3 (en) The use of substituted derivatives of 4-phenyl-6-aminonicotinic acid as medicaments
CZ217495A3 (en) 2,3-cyclically condensed 1,4-dihydropyridines, process of their preparation, medicaments in which said substances are comprised and their use
SK120793A3 (en) 4-heterocyclylsubstituted dihydropyridines
JP2007091750A (ja) フエニル−置換１，４−ジヒドロピリジン類の製造法
EP0488345B1 (en) Optically active 1,4-Dihydropyridine derivatives and methods of producing the same
US6001857A (en) Heterocyclyl substituted dihydropyridines
US6066655A (en) 4-phenyl-3-substituted 1,4-dihydropyridine esters
JP3751041B2 (ja) ４−（２−クロロ−３−シアノ−フエニル）−１，４−ジヒドロ−２，６−ジメチル−ピリジン−３，５−ジカルボン酸イソプロピル ２−メトキシエチル
SK158095A3 (en) Application of 1,2-bridged 1,4-dihydropyridines, 1,2-bridged 1,4-dihydropyridines, manufacturing process thereof and pharmaceutical compositions containing them
JPH06199849A (ja) ４−ヘテロシクロフエニル−置換されたジヒドロピリジン類
US5658934A (en) Aryl-substituted alkoxycarbonyl-1,4-dihydropyridine-5-carboxylic acid esters
SK47794A3 (en) Chinolyl-dihydropyridinecarboxylic acid esters, method of their production, medicines containing these matters, method of their production and using of these compounds
JPH07196616A (ja) 置換されたエステル類を有するジヒドロピリジン類
DE4342194A1 (de) Halogen-phenyl-substituierte 1,4-Dihydropyridine
DE4236705A1 (de) 4-Pyrrolylphenyl substituierte Dihydropyridine
SK2996A3 (en) Methanoanthracenes substituted by piperidinyl group, preparation method thereof and their use as d1/d2-dopamine-antagonists and 5ht2-serotonin-antagonists